Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: The Fierce 50 of 2024
Neupogen
Pharma
Coherus' Neulasta biosim nod steps up pressure on Amgen
Coherus won an FDA nod for its biosimilar to Amgen's Neulasta, heating up the market share fight—and touching off predictions of price competition.
Eric Sagonowsky
Nov 5, 2018 12:05pm
Pfizer wins approval of Nivestym, biosimilar of Amgen's Neupogen
Jul 23, 2018 11:09am
Novartis seeks to revive Neulasta biosim prospects with new data
Dec 8, 2017 10:03am
Express Scripts formulary knocks Lilly, Amgen meds—plus 62 more
Jul 31, 2017 12:12pm
As SCOTUS steps into biosim tangle, experts weigh in
Apr 27, 2017 12:06pm
Amgen, Sandoz argue biosimilars case before Supreme Court
Apr 26, 2017 11:59am
